AMRC vs CMPR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company exhibits weak financial health with a Piotroski F-Score of just 2/9, indicating significant fundamental deterioration. Despite recent earnings surprises and positive short-term growth momentum, high leverage (Debt/Equity of 2.25), low profitability margins, and a lack of Altman Z-Score due to potential distress risk raise serious concerns. The stock trades well above its Graham Number of $23.05 and intrinsic value of $19.06, implying overvaluation relative to defensive and growth-based metrics. Bearish insider activity and inconsistent earnings performance further undermine confidence in a sustainable turnaround.
CMPR shows bearish fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Concerns include weak profitability or high valuation.
Compare Another Pair
Related Comparisons
AMRC vs CMPR: Head-to-Head Comparison
This page compares Ameresco, Inc. (AMRC) and Cimpress plc (CMPR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.